OLGA SLEPCHENKO: Open Payments
NPI 1538558960 · CONCORD, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$762 in 45 payments from 14 companies in 2025. Trend: 2023 $394 · 2024 $1,069 · 2025 $762
Food & beverage: $762
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 10 | $162 |
| Axsome Therapeutics, Inc. | 11 | $143 |
| Alkermes, Inc. | 4 | $82 |
| ABBVIE INC. | 3 | $76 |
| E.R. Squibb & Sons, L.L.C. | 3 | $58 |
| Almatica Pharma LLC | 3 | $52 |
| Teva Pharmaceuticals USA, Inc. | 2 | $34 |
| Neos Therapeutics, LP | 2 | $34 |
| Vanda Pharmaceuticals Inc. | 2 | $30 |
| Neurocrine BioSciences, Inc. | 1 | $21 |
Products named: REXULTI, Sunosi, ARISTADA, VRAYLAR, COBENFY, Auvelity, LOREEV XR, HETLIOZ.
Industry payments across NC — which companies pay providers there.
